CD34 and neoplasm: Additionally, while achieving HLA matching between donor HSCs and tumors poses challenges in simulating fully functional human immune systems, several studies have indicated no significant correlation between the anti-tumor responses of PD-1/PD-L1 ICIs and HLA matching in CD34+ Hu-mice16,35.